Page last updated: 2024-09-03

n(6)-carboxymethyllysine and Chronic Illness

n(6)-carboxymethyllysine has been researched along with Chronic Illness in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (50.00)29.6817
2010's4 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ballerin, L; Boschetto, P; Campo, I; Casimirri, E; Ceconi, C; Fabbri, LM; Fucili, A; Gorrini, M; Luisetti, M; Papi, A; Potena, A; Stendardo, M; Tinelli, C1
Cai, W; Chen, X; Goodman, S; Pyzik, R; Ramdas, M; Striker, GE; Uribarri, J; Vlassara, H; Zhu, L1
de la Maza, MP; del Castillo, MD; Filip, R; Garay-Sevilla, ME; Gugliucci, A; Luevano-Contreras, C; Macías-Cervantes, MH; Markowicz Bastos, DH; Medrano, A; Menini, T; Portero-Otin, M; Rojas, A; Sampaio, GR; Uribarri, J; Wrobel, K1
Bandinelli, S; Ferrucci, L; Fink, JC; Guralnik, JM; Semba, RD; Sun, K1
Ferrucci, L; Fink, JC; Semba, RD; Sun, K; Windham, BG1
Baynes, JW1
Hwang, JS; Shin, CH; Yang, SW1
Gressner, AM; Kiefer, P; Lahme, B; Manns, MP; Tacke, F; Trautwein, C; Weiss, C; Yagmur, E1

Reviews

1 review(s) available for n(6)-carboxymethyllysine and Chronic Illness

ArticleYear
Dietary advanced glycation end products and their role in health and disease.
    Advances in nutrition (Bethesda, Md.), 2015, Volume: 6, Issue:4

    Topics: Agriculture; Chronic Disease; Cooking; Diet; Exercise; Food; Food Handling; Glycation End Products, Advanced; Health Status; Hot Temperature; Humans; Inflammation; Lysine; Mexico; Neurodegenerative Diseases; Oxidative Stress; Receptor for Advanced Glycation End Products; Solubility

2015

Trials

1 trial(s) available for n(6)-carboxymethyllysine and Chronic Illness

ArticleYear
Suppression of native defense mechanisms, SIRT1 and PPARγ, by dietary glycoxidants precedes disease in adult humans; relevance to lifestyle-engendered chronic diseases.
    Amino acids, 2014, Volume: 46, Issue:2

    Topics: Aged; Biomarkers; Cell Line; Chronic Disease; Cooking; Feeding Behavior; Female; Gene Expression; Gene Silencing; Glycation End Products, Advanced; Humans; Life Style; Lysine; Male; Middle Aged; Oxidative Stress; PPAR gamma; Sirtuin 1

2014

Other Studies

6 other study(ies) available for n(6)-carboxymethyllysine and Chronic Illness

ArticleYear
Plasma sRAGE and N-(carboxymethyl) lysine in patients with CHF and/or COPD.
    European journal of clinical investigation, 2013, Volume: 43, Issue:6

    Topics: Aged; Biomarkers; Case-Control Studies; Chronic Disease; Enzyme-Linked Immunosorbent Assay; Female; Glycation End Products, Advanced; Heart Failure; Humans; Lysine; Male; Natriuretic Peptide, Brain; Peptide Fragments; Pulmonary Disease, Chronic Obstructive

2013
Carboxymethyl-lysine, an advanced glycation end product, and decline of renal function in older community-dwelling adults.
    European journal of nutrition, 2009, Volume: 48, Issue:1

    Topics: Aged; Aged, 80 and over; Chronic Disease; Cross-Sectional Studies; Educational Status; Female; Glomerular Filtration Rate; Glycation End Products, Advanced; Humans; Kidney Diseases; Kidney Function Tests; Logistic Models; Longitudinal Studies; Lysine; Male; Mental Status Schedule; Odds Ratio; Sex Characteristics; Smoking

2009
Serum carboxymethyl-lysine, a dominant advanced glycation end product, is associated with chronic kidney disease: the Baltimore longitudinal study of aging.
    Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation, 2010, Volume: 20, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Aging; Baltimore; Chronic Disease; Cross-Sectional Studies; Female; Glomerular Filtration Rate; Glycation End Products, Advanced; Humans; Kidney Diseases; Linear Models; Longitudinal Studies; Lysine; Male; Middle Aged; Racial Groups; Smoking

2010
The clinical chemome: a tool for the diagnosis and management of chronic disease.
    Clinical chemistry, 2004, Volume: 50, Issue:7

    Topics: Biomarkers; Chromatography, Liquid; Chronic Disease; Glycation End Products, Advanced; Humans; Lipid Metabolism; Lipids; Lysine; Mass Spectrometry; Oxidation-Reduction; Renal Dialysis; Renal Insufficiency

2004
Clinical implications of N epsilon-(carboxymethyl)lysine, advanced glycation end product, in children and adolescents with type 1 diabetes.
    Diabetes, obesity & metabolism, 2005, Volume: 7, Issue:3

    Topics: Adolescent; Biomarkers; Case-Control Studies; Child; Chronic Disease; Diabetes Complications; Diabetes Mellitus, Type 1; Enzyme-Linked Immunosorbent Assay; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Linear Models; Lysine; Male

2005
Elevation of Nepsilon-(carboxymethyl)lysine-modified advanced glycation end products in chronic liver disease is an indicator of liver cirrhosis.
    Clinical biochemistry, 2006, Volume: 39, Issue:1

    Topics: Adolescent; Adult; Aged; Chronic Disease; Female; Glycation End Products, Advanced; Humans; Hyaluronic Acid; Liver Cirrhosis; Lysine; Male; Middle Aged

2006